HB 4490 creates the Oklahoma Families Thriving Everywhere Now (OFTEN) program through the Oklahoma State Department of Health, using $3 million in state funds for the 2027 fiscal year. The program provides telecare support, community outreach, and care coordination for women with high-risk pregnancies and parents of children under three, aiming to promote healthy childbirth, stable family formation, and economic self-sufficiency. Services include referrals, case management, and parenting assistance delivered by Oklahoma-based community providers. The bill takes effect July 1, 2026, and includes an emergency declaration to accelerate implementation.
HB 2788 transfers specific funds back into Oklahoma's Statewide Recovery Fund from several existing programs. It moves $1.56 million from domestic violence services, $162,668 from food assistance programs, $1.49 million from health workforce initiatives, $2.16 million from rural healthcare, $5 million from medical facilities, $20.5 million from mental health hospital construction, and $3.3 million from water resources projects. All transfers align with recommendations from the Joint Committee on Pandemic Relief Funding. The bill takes effect July 1, 2025, and was enacted without the governor's signature on May 29, 2025.
SB 109 requires Oklahoma health insurance plans to cover genetic testing for inherited cancer risks and evidence-based cancer imaging for individuals with a personal or family history of cancer or increased cancer risk. This coverage must be provided without patient cost-sharing (such as deductibles or copays) when ordered by a healthcare provider following current medical guidelines, including those from the National Comprehensive Cancer Network. The law applies to all health benefit plans offered in Oklahoma starting November 1, 2025, ensuring these preventive services are accessible without financial barriers. It does not affect health savings account eligibility for non-preventive services but guarantees coverage for preventive care under federal guidelines.
SB 176 requires health insurance plans to cover certain prescription drugs that were previously not included in standard coverage. It directly affects health insurance providers and policyholders by mandating this specific coverage for eligible medications. The key provision is a new requirement for all health benefit plans to include these designated prescriptions without prior authorization or excessive cost-sharing. The law became effective on May 29, 2025, after the Governor did not sign it.
SB 927 amends Oklahoma's Medicaid Drug Utilization Review Board procedures by prohibiting the pharmaceutical industry representative from voting on drug-related matters. It updates the appointment process to stagger initial terms for one physician, one pharmacist, and the lay representative to ensure board continuity. The bill affects the Oklahoma Health Care Authority and the board members, with changes taking effect November 1, 2025. The board's composition (10 members: 4 physicians, 4 pharmacists, 1 lay representative, 1 pharmaceutical industry rep) and appointment lists remain unchanged.
SB 95 updates key definitions in Oklahoma's workers' compensation law to clarify eligibility and claims processing. It directly affects injured workers (claimants), employers, insurance carriers, and medical providers by defining terms like "case manager" (requiring specific nursing licenses or certifications) and "carrier" (explicitly including self-insured employers). The bill also clarifies what constitutes a "compensable injury," excluding age-related conditions like arthritis and adding drug testing rules for claims involving intoxication. These changes aim to standardize claims administration and reduce disputes over coverage. The bill became effective after the governor signed it on May 6, 2025.
HB 2087 modifies Oklahoma's income tax credit for donations to qualified research institutes. It adjusts annual funding caps: for biomedical research institutes, the limit drops from $2 million to $1.5 million per year starting in 2026, while cancer research institute credits are capped at $500,000 annually. The credit percentage for each donation type is recalculated yearly based on prior-year claims, using specific formulas to stay within these new limits. Taxpayers donating to qualifying nonprofit biomedical or cancer research institutes (defined by NIH funding requirements) can claim the credit, with individual limits of $1,000-$25,000 depending on filing status or business type.
HB 2012 removes the July 1, 2026, expiration date for Oklahoma's harm-reduction services program, making it permanent. It authorizes government agencies, religious institutions, nonprofits, for-profit companies, and tribal governments to provide services including needle distribution, HIV/hepatitis testing, referrals for addiction treatment, and safe needle disposal. Providers must register with the State Department of Health and report quarterly on services delivered, such as the number of people served, needles distributed, and test results. This bill directly affects people who use injection drugs by expanding access to health services aimed at reducing disease transmission and overdose risks.
HB 2233 updates Oklahoma's Massage Therapy Practice Act by clarifying licensing rules and scope of practice for massage therapists. It directly affects licensed massage therapists, massage therapy schools, and other health professionals who may provide massage services. Key changes include renaming the regulating board to the Oklahoma Board of Medical Licensure and Supervision, explicitly allowing "direct access" (public can seek massage without medical referral), and defining massage therapy as soft tissue techniques (e.g., touch, pressure, heat) while prohibiting diagnosis, prescribing, or medical techniques like ultrasound. The bill also clarifies exemptions for physicians, students, and specific practices like the Feldenkrais Method when performed within their established professional scope.
